NO20080262L - Fremgangsmate for produksjonen av intermediater for fremstilling av tricykliske benzimidazoler - Google Patents
Fremgangsmate for produksjonen av intermediater for fremstilling av tricykliske benzimidazolerInfo
- Publication number
- NO20080262L NO20080262L NO20080262A NO20080262A NO20080262L NO 20080262 L NO20080262 L NO 20080262L NO 20080262 A NO20080262 A NO 20080262A NO 20080262 A NO20080262 A NO 20080262A NO 20080262 L NO20080262 L NO 20080262L
- Authority
- NO
- Norway
- Prior art keywords
- production
- intermediates
- compounds
- formula
- tricyclic benzimidazoles
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 150000001556 benzimidazoles Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05105566 | 2005-06-22 | ||
| EP06101699 | 2006-02-15 | ||
| PCT/EP2006/063350 WO2006136552A2 (en) | 2005-06-22 | 2006-06-20 | Process for the production of intermadiates for the preparation of tricyclic benzimidazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20080262L true NO20080262L (no) | 2008-01-18 |
Family
ID=37067521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20080262A NO20080262L (no) | 2005-06-22 | 2008-01-15 | Fremgangsmate for produksjonen av intermediater for fremstilling av tricykliske benzimidazoler |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080280855A1 (pt) |
| EP (1) | EP1904454A2 (pt) |
| JP (1) | JP2008546736A (pt) |
| KR (1) | KR20080028413A (pt) |
| AR (1) | AR057389A1 (pt) |
| AU (1) | AU2006260960A1 (pt) |
| BR (1) | BRPI0612059A2 (pt) |
| CA (1) | CA2612112A1 (pt) |
| EA (1) | EA200702587A1 (pt) |
| IL (1) | IL187746A0 (pt) |
| MX (1) | MX2007015087A (pt) |
| NO (1) | NO20080262L (pt) |
| TW (1) | TW200726752A (pt) |
| WO (1) | WO2006136552A2 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008035195A1 (en) * | 2006-09-21 | 2008-03-27 | Raqualia Pharma Inc. | Benzimidazole derivatives as selective acid pump inhibitors |
| WO2008095912A2 (en) * | 2007-02-06 | 2008-08-14 | Nycomed Gmbh | Enantiopure pharmacologically active tricyclic benzimidazoles |
| US8648080B2 (en) | 2009-07-09 | 2014-02-11 | Raqualia Pharma Inc. | Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility |
| US8912324B2 (en) * | 2010-09-01 | 2014-12-16 | Ambit Biosciences Corporation | Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof |
| WO2016126721A1 (en) | 2015-02-02 | 2016-08-11 | Forma Therapeutics, Inc. | 3-aryl-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors |
| WO2016126726A1 (en) | 2015-02-02 | 2016-08-11 | Forma Therapeutics, Inc. | Bicyclic [4,6,0] hydroxamic acids as hdac6 inhibitors |
| EP3472131B1 (en) | 2016-06-17 | 2020-02-19 | Forma Therapeutics, Inc. | 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4919562B2 (ja) * | 2001-09-28 | 2012-04-18 | 日本曹達株式会社 | ルテニウムヒドリド錯体、アルコール化合物の製造方法およびラセミ体カルボニル化合物の分割方法 |
| US6878838B2 (en) * | 2003-03-24 | 2005-04-12 | The University Of North Carolina At Chapel Hill | Chiral porous metal phosphonates for heterogeneous asymmetric catalysis |
| WO2004087701A1 (en) * | 2003-04-04 | 2004-10-14 | Altana Pharma Ag | Cyclic benzimidazoles |
| AR046941A1 (es) * | 2003-12-19 | 2006-01-04 | Altana Pharma Ag | Imidazopiridinas triciclicas y su uso como inhibidores de secrecion de acido gastrico |
| US7326784B2 (en) * | 2003-12-19 | 2008-02-05 | Altana Pharma Ag | Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives |
-
2006
- 2006-06-20 BR BRPI0612059-8A patent/BRPI0612059A2/pt not_active Application Discontinuation
- 2006-06-20 AU AU2006260960A patent/AU2006260960A1/en not_active Abandoned
- 2006-06-20 TW TW095122113A patent/TW200726752A/zh unknown
- 2006-06-20 EP EP06763796A patent/EP1904454A2/en not_active Withdrawn
- 2006-06-20 WO PCT/EP2006/063350 patent/WO2006136552A2/en not_active Ceased
- 2006-06-20 CA CA002612112A patent/CA2612112A1/en not_active Abandoned
- 2006-06-20 MX MX2007015087A patent/MX2007015087A/es not_active Application Discontinuation
- 2006-06-20 US US11/922,213 patent/US20080280855A1/en not_active Abandoned
- 2006-06-20 KR KR1020087000276A patent/KR20080028413A/ko not_active Withdrawn
- 2006-06-20 JP JP2008517482A patent/JP2008546736A/ja active Pending
- 2006-06-20 EA EA200702587A patent/EA200702587A1/ru unknown
- 2006-06-21 AR ARP060102649A patent/AR057389A1/es unknown
-
2007
- 2007-11-29 IL IL187746A patent/IL187746A0/en unknown
-
2008
- 2008-01-15 NO NO20080262A patent/NO20080262L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2612112A1 (en) | 2006-12-28 |
| IL187746A0 (en) | 2008-04-13 |
| WO2006136552A2 (en) | 2006-12-28 |
| JP2008546736A (ja) | 2008-12-25 |
| US20080280855A1 (en) | 2008-11-13 |
| TW200726752A (en) | 2007-07-16 |
| KR20080028413A (ko) | 2008-03-31 |
| AU2006260960A1 (en) | 2006-12-28 |
| AR057389A1 (es) | 2007-12-05 |
| EA200702587A1 (ru) | 2008-06-30 |
| EP1904454A2 (en) | 2008-04-02 |
| WO2006136552A3 (en) | 2007-03-29 |
| BRPI0612059A2 (pt) | 2010-10-13 |
| MX2007015087A (es) | 2008-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX340572B (es) | Proceso para la fabricacion de compuestos farmaceuticamente activos. | |
| NO20083909L (no) | Bisykliske benzimidazolforbindelser, og deres anvendelse som metabotropiske glutamatreseptorforsterkere | |
| NO20073663L (no) | Tiazol-4-karboksamid-derivater som mGluR5 antagonister | |
| CY1111045T1 (el) | Μεθοδος παραγωγης ενος παραγωγου βενζιμιδαζολιου | |
| NO20081476L (no) | Substituerte benzimidazoler og fremgangsmater for fremstilling | |
| MY155626A (en) | Organic compounds. | |
| CY1116885T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου | |
| WO2012015681A3 (en) | Drug-ligand conjugates, synthesis thereof, and intermediates thereto | |
| TW200942535A (en) | Novel compounds as cannabinoid receptor ligands | |
| NO20080394L (no) | N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav | |
| NO20071254L (no) | Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav. | |
| EA201070779A1 (ru) | Триазолсодержащие производные оксадиазола | |
| ECSP099708A (es) | Nuevos métodos | |
| HK1215579A1 (zh) | 被取代的2，3-二氫苯並呋喃基化合物和其用途 | |
| EA201100696A1 (ru) | 1-(арилсульфонил)-4-(пиперазин-1-ил)-1h-бензимидазолы в качестве лигандов 5-гидрокситриптамина-6 | |
| MY148769A (en) | Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments | |
| NO20070089L (no) | DPP-IV inhibitorer | |
| JO2734B1 (en) | Organic compounds | |
| MX2009008221A (es) | Antagonista de receptor de cromeno s1p1. | |
| NO20076161L (no) | Fremgangsmater for fremstilling av 4-bifenylazetidin-2-oner | |
| TW200716564A (en) | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
| TW200726752A (en) | Process for the production of intermediates for the preparation of tricyclic benzimidazoles | |
| NO20082589L (no) | Nye indolizinderivater, fremgangsmate for fremstilling av samme og terapeutiske sammensetninger som inbefatter samme | |
| TW200621703A (en) | Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
| NO20081529L (no) | Naftyridinderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |
|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |